{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:05:42Z","timestamp":1792242342766,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017209","name":"Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015068","name":"Universidade de Santiago de Compostela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-099597-B- 100"],"award-info":[{"award-number":["RTI2018-099597-B- 100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejpb.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T11:43:30Z","timestamp":1645098210000},"page":"144-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery"],"prefix":"10.1016","volume":"172","author":[{"given":"Rub\u00e9n","family":"Varela-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurxo","family":"Garc\u00eda-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"D\u00edaz-Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ux\u00eda","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gonz\u00e1lez-Barcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Isabel Lema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Javier Otero-Espinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpb.2022.02.010_b0005","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular Drug Delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.ejpb.2022.02.010_b0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic Drug Delivery Systems-Recent Advances","volume":"17","author":"Le Bourlais","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"issue":"7","key":"10.1016\/j.ejpb.2022.02.010_b0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid Lipid Nanoparticles for Ocular Drug Delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.ejpb.2022.02.010_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09687688.2010.510804","article-title":"Nanoparticulate Drug Delivery Systems for Cancer Chemotherapy","volume":"27","author":"Saha","year":"2010","journal-title":"Mol. Membr. Biol."},{"issue":"9","key":"10.1016\/j.ejpb.2022.02.010_b0030","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.xphs.2017.02.026","article-title":"Recent Trends in Clinical Trials Related to Carrier-Based Drugs","volume":"106","author":"Tagami","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.02.010_b0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the Design of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Targeting Brain Diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ejpb.2022.02.010_b0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure Preparation and Application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2022.02.010_b0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular Drug Delivery Systems: An Overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.02.010_b0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejpb.2016.10.013","article-title":"Lipid Nanoparticles (SLN, NLC): Overcoming the Anatomical and Physiological Barriers of the Eye - Part II - Ocular Drug-Loaded Lipid Nanoparticles","volume":"110","author":"S\u00e1nchez-L\u00f3pez","year":"2017","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV"},{"issue":"11","key":"10.1016\/j.ejpb.2022.02.010_b0055","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1248\/cpb.49.1444","article-title":"In Vitro and in Vivo Study of Two Types of Long-Circulating Solid Lipid Nanoparticles Containing Paclitaxel","volume":"49","author":"Chen","year":"2001","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.010_b0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/phrs.2000.0695","article-title":"Non-Stealth and Stealth Solid Lipid Nanoparticles (SLN) Carrying Doxorubicin: Pharmacokinetics and Tissue Distribution after i.v. Administration to Rats","volume":"42","author":"Fundar\u00f2","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejpb.2022.02.010_b0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery - a Review of the State of the Art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV"},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/02652040010018056","article-title":"Production of Solid Lipid Nanoparticles (SLN): Scaling up Feasibilities","volume":"19","author":"Dingler","year":"2002","journal-title":"J. Microencapsul."},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.010_b0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","article-title":"Correlation between Long-Term Stability of Solid Lipid Nanoparticles (SLN) and Crystallinity of the Lipid Phase","volume":"47","author":"Freitas","year":"1999","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV"},{"key":"10.1016\/j.ejpb.2022.02.010_b0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid Lipid Nanoparticles: Production, Characterization and Applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.010_b0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajo.2007.11.017","article-title":"Collaborative Longitudinal Evaluation of Keratoconus Study Group Changes in the Quality-of-Life of People with Keratoconus","volume":"145","author":"Kymes","year":"2008","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.010_b0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clae.2010.04.006","article-title":"Keratoconus: A review","volume":"33","author":"Romero-Jim\u00e9nez","year":"2010","journal-title":"Contact Lens and Anterior Eye J. Br. Contact Lens Assoc."},{"key":"10.1016\/j.ejpb.2022.02.010_b0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ICO.0000000000000723","article-title":"Efficacy of Corneal Collagen Cross-Linking for the Treatment of Keratoconus: A Systematic Review and Meta-Analysis","volume":"35","author":"Meiri","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2022.02.010_b0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.preteyeres.2018.05.002","article-title":"Pathogenesis of Keratoconus: The Intriguing Therapeutic Potential of Prolactin-Inducible Protein","volume":"67","author":"Sharif","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.010_b0105","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ophtha.2004.11.050","article-title":"Inflammatory Molecules in the Tears of Patients with Keratoconus","volume":"112","author":"Lema","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2022.02.010_b0110","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1111\/j.1755-3768.2011.02369.x","article-title":"Proteases, Proteolysis and Inflammatory Molecules in the Tears of People with Keratoconus","volume":"90","author":"Balasubramanian","year":"2012","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.ejpb.2022.02.010_b0115","first-page":"2055","article-title":"Proteomic Analysis of the Tear Film in Patients with Keratoconus","volume":"16","author":"Lema","year":"2010","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.exer.2011.12.010","article-title":"Levels of Lactoferrin, Secretory IgA and Serum Albumin in the Tear Film of People with Keratoconus","volume":"96","author":"Balasubramanian","year":"2012","journal-title":"Exp. Eye Res."},{"issue":"301","key":"10.1016\/j.ejpb.2022.02.010_b0125","first-page":"e1","article-title":"Lactoferrin: Structure, Function and Applications","volume":"33","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejpb.2022.02.010_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-0-387-74087-4_6","article-title":"Lactoferrin Structure and Functions","volume":"606","author":"Legrand","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejpb.2022.02.010_b0135","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/iai.62.6.2628-2632.1994","article-title":"Lactoferrin Is a Lipid A-Binding Protein","volume":"62","author":"Appelmelk","year":"1994","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.010_b0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1292\/jvms.66.149","article-title":"Oral Administration of Lactoferrin Inhibits Inflammation and Nociception in Rat Adjuvant-Induced Arthritis","volume":"66","author":"Hayashida","year":"2004","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejpb.2022.02.010_b0145","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/iai.56.5.1144-1149.1988","article-title":"Identification and Characterization of the Human Lactoferrin-Binding Protein from Neisseria Meningitidis","volume":"56","author":"Schryvers","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejpb.2022.02.010_b0150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1172\/JCI115407","article-title":"Killing of Gram-Negative Bacteria by Lactoferrin and Lysozyme","volume":"88","author":"Ellison","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ejpb.2022.02.010_b0155","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1128\/AAC.47.8.2619-2623.2003","article-title":"Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice","volume":"47","author":"Takakura","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.010_b0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004300050093","article-title":"Inhibition of Poliovirus Type 1 Infection by Iron-, Manganese- and Zinc-Saturated Lactoferrin","volume":"187","author":"Marchetti","year":"1999","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"issue":"6","key":"10.1016\/j.ejpb.2022.02.010_b0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1292\/jvms.63.637","article-title":"Characterization of in Vitro and in Vivo Antiviral Activity of Lactoferrin and Ribavirin upon Hantavirus","volume":"63","author":"Murphy","year":"2001","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejpb.2022.02.010_b0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/B:BIOM.0000027707.82911.be","article-title":"The Antiviral Activity of the Milk Protein Lactoferrin against the Human Immunodeficiency Virus Type 1","volume":"17","author":"Berkhout","year":"2004","journal-title":"Biometals"},{"key":"10.1016\/j.ejpb.2022.02.010_b0175","first-page":"2703","article-title":"Evidence for a Direct Antitumor Mechanism of Action of Bovine Lactoferricin","volume":"22","author":"Eliassen","year":"2002","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1139\/o01-239","article-title":"Cancer Prevention by Bovine Lactoferrin and Underlying Mechanisms\u2013a Review of Experimental and Clinical Studies","volume":"80","author":"Tsuda","year":"2002","journal-title":"Biochem. Cell Biol. Biochim. Biol. Cell."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biochi.2008.07.007","article-title":"Role of Lactoferrin in the Tear Film","volume":"91","author":"Flanagan","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.ejpb.2022.02.010_b0190","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1167\/iovs.08-1882","article-title":"Bovine Lactoferrin Stimulates Human Corneal Epithelial Alkali Wound Healing in Vitro","volume":"50","author":"Pattamatta","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2022.02.010_b0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like Receptor Signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2022.02.010_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13525-7","article-title":"Higher Expression of Toll-Like Receptors 2 and 4 in Blood Cells of Keratoconus Patiens","volume":"7","author":"Sobrino","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejpb.2022.02.010_b0205","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.preteyeres.2012.05.003","article-title":"Ocular Surface Inflammation Is Regulated by Innate Immunity","volume":"31","author":"Ueta","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2022.02.010_b0210","unstructured":"Gesto, M.I.L.; S\u00e1nchez, J.A.C.; MOREIRAS, T.S.; Perez, F.C. Biomarkers for Diagnosis and Prognosis of Corneal Ectatic Disorders 2016."},{"issue":"3","key":"10.1016\/j.ejpb.2022.02.010_b0215","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1021\/acsami.0c18926","article-title":"Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan\/TPP and Chitosan\/Sulfobutylether-\u03b2-Cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment","volume":"13","author":"Varela-Fern\u00e1ndez","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.ejpb.2022.02.010_b0220","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s11095-005-7148-5","article-title":"Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy","volume":"22","author":"Jores","year":"2005","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010611-134623","article-title":"Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective","volume":"52","author":"Moghimi","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/17425247.2014.950564","article-title":"The Importance of Nanoparticle Shape in Cancer Drug Delivery","volume":"12","author":"Truong","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2022.02.010_b0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/2230-973X.82432","article-title":"Preparation and Characterization of Albumin Nanoparticles Encapsulating Curcumin Intended for the Treatment of Breast Cancer","volume":"1","author":"Jithan","year":"2011","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ejpb.2022.02.010_b0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-511X-11-159","article-title":"Nanostructured Lipid Carriers: A Potential Drug Carrier for Cancer Chemotherapy","volume":"11","author":"Selvamuthukumar","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejpb.2022.02.010_b0245","unstructured":"Q 1 A (R2) Stability Testing of New Drug Substances and Products. 2006, 20."},{"key":"10.1016\/j.ejpb.2022.02.010_b0250","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/156720109787048302","article-title":"Poly (D, L-Lactide) Nanosuspensions of Risperidone for Parenteral Delivery: Formulation and in-Vitro Evaluation","volume":"6","author":"Muthu","year":"2009","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2022.02.010_b0255","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/js950474+","article-title":"Comparative in Vitro Evaluation of Several Colloidal Systems, Nanoparticles, Nanocapsules, and Nanoemulsions, as Ocular Drug Carriers","volume":"85","author":"Calvo","year":"1996","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2022.02.010_b0260","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s11095-010-0275-7","article-title":"Anticancer Drug-Loaded Nanospheres Based on Biodegradable Amphiphilic \u03b5-Caprolactone and Carbonate Copolymers","volume":"27","author":"Yan","year":"2010","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0278-6915(96)00100-7","article-title":"IRAG Working Group 1. Organotypic Models for the Assessment\/Prediction of Ocular Irritation. Interagency Regulatory Alternatives Group","volume":"35","author":"Chamberlain","year":"1997","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"issue":"6","key":"10.1016\/j.ejpb.2022.02.010_b0270","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0887-2333(95)00092-5","article-title":"The EC\/HO International Validation Study on Alternatives to the Draize Eye Irritation Test","volume":"9","author":"Balls","year":"1995","journal-title":"Toxicol. Vitro Int. J. Publ. Assoc. BIBRA"},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10915819609008705","article-title":"Soaps and Detergents: Alternatives to Animal Eye Irritation Tests","volume":"15","author":"Christian","year":"1996","journal-title":"J. Am. Coll. Toxicol."},{"key":"10.1016\/j.ejpb.2022.02.010_b0280","doi-asserted-by":"crossref","unstructured":"Loprieno, N. Alternative Methodologies for the Safety Evaluation of Chemicals in the Cosmetic Industry; CRC Press, 2019; ISBN 978-1-00-069678-3.","DOI":"10.1201\/9780429283765-1"},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/15376519409049111","article-title":"A Multitest Approach to Evaluating Ocular Irritation in Vitro","volume":"4","author":"Sina","year":"1994","journal-title":"Toxicol. Methods"},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.010_b0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.vascn.2010.01.001","article-title":"Validating and Troubleshooting Ocular In Vitro Toxicology Tests","volume":"61","author":"Barile","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.010_b0295","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/01926230290105730","article-title":"Book Review: Handbook of Toxicology, 2nd edition, Edited by Derelanko MJ and Hollinger MA, CRC Press, 1,414 pages, numerous tables and figures, 2001, Price $149.95","volume":"30","author":"Wagner","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ejpb.2022.02.010_b0300","doi-asserted-by":"crossref","unstructured":"Salem, H.; Katz, S.A. Alternative Toxicological Methods; CRC Press, 2003; ISBN 978-0-203-00879-9.","DOI":"10.1201\/9780203008799"},{"key":"10.1016\/j.ejpb.2022.02.010_b0305","unstructured":"Eskes, C.; Bessou, S.; Bruner, L.; Curren, R.; Jones, P.; Kreiling, R.; Liebsch, M.; McNamee, P.; Pape, W.; Prinsen, M.K.; et al. Subgroup 3. Eye Irritation. 76."},{"key":"10.1016\/j.ejpb.2022.02.010_b0310","doi-asserted-by":"crossref","unstructured":"Sina, J.F.; Galer, D.M.; Sussman, R.G.; Gautheron, P.D.; Sargent, E.V.; Leong, B.; Shah, P.V.; Curren, R.D.; Miller, K. A Collaborative Evaluation of Seven Alternatives to the Draize Eye Irritation Test Using Pharmaceutical Intermediates. Fundam. Appl. Toxicol. 1995, 26, 20\u201331, doi:10.1006\/faat.1995.1071.","DOI":"10.1093\/toxsci\/26.1.20"},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.010_b0315","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0278-6915(85)90030-4","article-title":"Hen\u2019s Egg Chorioallantoic Membrane Test for Irritation Potential","volume":"23","author":"Luepke","year":"1985","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"issue":"4-5","key":"10.1016\/j.ejpb.2022.02.010_b0320","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0887-2333(90)90147-L","article-title":"A National Validation Project of Alternative Methods to the Draize Rabbit Eye Test","volume":"4","author":"Kalweit","year":"1990","journal-title":"Toxicol. Vitro Int. J. Publ. Assoc. BIBRA"},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.010_b0325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0887-2333(93)90055-A","article-title":"Validation Study of Alternatives to the Draize Eye Irritation Test in Germany: Cytotoxicity Testing and HET-CAM Test with 136 Industrial Chemicals","volume":"7","author":"Spielmann","year":"1993","journal-title":"Toxicol. Vitro Int. J. Publ. Assoc. BIBRA"},{"key":"10.1016\/j.ejpb.2022.02.010_b0330","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/156720109787048285","article-title":"Formulation and Evaluation of Oral Mucoadhesive Multiparticulate System Containing Metoprolol Tartarate: An in Vitro-Ex Vivo Characterization","volume":"6","author":"Belgamwar","year":"2009","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2022.02.010_b0335","first-page":"2523","article-title":"Chemical Coupling of Thiolated Chitosan to Preformed Liposomes Improves Mucoadhesive Properties","volume":"7","author":"Gradauer","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.ejpb.2022.02.010_b0340","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1021\/mp300382n","article-title":"In Vivo Biodistribution of Amino-Functionalized Ceria Nanoparticles in Rats Using Positron Emission Tomography","volume":"9","author":"Rojas","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2022.02.010_b0345","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1039\/c2an35863h","article-title":"Tracing Nanoparticles in Vivo: A New General Synthesis of Positron Emitting Metal Oxide Nanoparticles by Proton Beam Activation","volume":"137","author":"P\u00e9rez-Campa\u00f1a","year":"2012","journal-title":"Analyst"},{"issue":"7","key":"10.1016\/j.ejpb.2022.02.010_b0350","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1021\/bm2005774","article-title":"Modifying the Body Distribution of HPMA-Based Copolymers by Molecular Weight and Aggregate Formation","volume":"12","author":"Allmeroth","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2022.02.010_b0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2013.07.027","article-title":"PEGylation of HPMA-Based Block Copolymers Enhances Tumor Accumulation in Vivo : A Quantitative Study Using Radiolabeling and Positron Emission Tomography","volume":"172","author":"Allmeroth","year":"2013","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2022.02.010_b0360","first-page":"772","article-title":"Positron Emission Tomography for the Development and Characterization of Corneal Permanence of Ophthalmic Pharmaceutical Formulations","volume":"58","author":"Fern\u00e1ndez-Ferreiro","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2022.02.010_b0365","unstructured":"The Association for Research in Vision and Ophthalmology- Statement for the Use of Animals in Ophthalmic and Vision Research Available online: https:\/\/www.arvo.org\/About\/policies\/statement-for-the-use-of-animals-in-ophthalmic-and-vision-research\/ (accessed on 22 July 2020)."},{"key":"10.1016\/j.ejpb.2022.02.010_b0370","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nantod.2016.06.007","article-title":"The 3Rs as a Framework to Support a 21st Century Approach for Nanosafety Assessment","volume":"12","author":"Burden","year":"2017","journal-title":"Nano Today"},{"issue":"3","key":"10.1016\/j.ejpb.2022.02.010_b0375","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An Add-in Program for Pharmacokinetic and Pharmacodynamic Data Analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"issue":"2-3","key":"10.1016\/j.ejpb.2022.02.010_b0380","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0927-7765(02)00053-X","article-title":"Design of Lipid Nanoparticles for the Oral Delivery of Hydrophilic Macromolecules","volume":"27","author":"Garc\u0131\u0301a-Fuentes","year":"2003","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.010_b0385","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-5173(97)04885-0","article-title":"Peptide-Loaded Solid Lipid Nanoparticles (SLN): Influence of Production Parameters","volume":"149","author":"Almeida","year":"1997","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2022.02.010_b0390","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1773-2247(11)50077-2","article-title":"Solid Lipid Nanosuspensions Based on Low Melting Lipids as Protective System of Retinyl Palmitate","volume":"21","author":"Cerreto","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.010_b0395","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2009.10.022","article-title":"Corticosteroid Solubility and Lipid Polarity Control Release from Solid Lipid Nanoparticles","volume":"390","author":"Jensen","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.010_b0400","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.colsurfb.2009.09.033","article-title":"Formulating Fluticasone Propionate in Novel PEG-Containing Nanostructured Lipid Carriers (PEG-NLC)","volume":"75","author":"Doktorovov\u00e1","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"10.1016\/j.ejpb.2022.02.010_b0405","doi-asserted-by":"crossref","first-page":"065002","DOI":"10.1088\/1748-6041\/5\/6\/065002","article-title":"A Modified Double-Emulsion Method for the Preparation of Daunorubicin-Loaded Polymeric Nanoparticle with Enhanced in Vitro Anti-Tumor Activity","volume":"5","author":"Liu","year":"2010","journal-title":"Biomed. Mater. Bristol Engl."},{"issue":"5","key":"10.1016\/j.ejpb.2022.02.010_b0410","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1248\/cpb.58.650","article-title":"Formulation and Evaluation of Solid Lipid Nanoparticles of a Water Soluble Drug: Zidovudine","volume":"58","author":"Singh","year":"2010","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejpb.2022.02.010_b0415","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1211\/0022357044959","article-title":"Solid Lipid Nanoparticles (SLNs) to Improve Oral Bioavailability of Poorly Soluble Drugs","volume":"56","author":"Hu","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.02.010_b0420","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","article-title":"Development and Evaluation of Lipid Nanoparticles for Camptothecin Delivery: A Comparison of Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, and Lipid Emulsion","volume":"29","author":"Huang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.ejpb.2022.02.010_b0425","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jps.10413","article-title":"Influence of Emulsifiers on the Crystallization of Solid Lipid Nanoparticles","volume":"92","author":"Bunjes","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.02.010_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5260976","article-title":"Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by Diclofenac","volume":"2018","author":"Abdelkader","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejpb.2022.02.010_b0435","doi-asserted-by":"crossref","unstructured":"Partheniades, E. Chapter 3 - Forces between Clay Particles and the Process of Flocculation. In Cohesive Sediments in Open Channels; Partheniades, E., Ed.; Butterworth-Heinemann: Boston, 2009; pp. 47\u201388 ISBN 978-1-85617-556-2.","DOI":"10.1016\/B978-1-85617-556-2.00003-2"},{"key":"10.1016\/j.ejpb.2022.02.010_b0440","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41598-018-23064-4","article-title":"Parameters Influencing the Size of Chitosan-TPP Nano- and Microparticles","volume":"8","author":"Sreekumar","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejpb.2022.02.010_b0445","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1039\/C1SM06518A","article-title":"Super Stable Foams Stabilized by Colloidal Ethyl Cellulose Particles","volume":"8","author":"Jin","year":"2012","journal-title":"Soft Matter"},{"issue":"3","key":"10.1016\/j.ejpb.2022.02.010_b0450","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/la404357j","article-title":"Irreversible Adsorption-Driven Assembly of Nanoparticles at Fluid Interfaces Revealed by a Dynamic Surface Tension Probe","volume":"30","author":"Bizmark","year":"2014","journal-title":"Langmuir ACS J. Surf. Colloids"},{"key":"10.1016\/j.ejpb.2022.02.010_b0455","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/iovs.13-12577","article-title":"Lipid-Modifying Enzymes in Human Tear Fluid and Corneal Epithelial Stress Response","volume":"55","author":"Robciuc","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2022.02.010_b0460","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1002\/jps.23251","article-title":"Nanostructured Lipid Carriers as Novel Ophthalmic Delivery System for Mangiferin: Improving in Vivo Ocular Bioavailability","volume":"101","author":"Liu","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.02.010_b0465","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","article-title":"Nanostructured Lipid Carrier (NLC) Coated with Chitosan Oligosaccharides and Its Potential Use in Ocular Drug Delivery System","volume":"403","author":"Luo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.02.010_b0470","first-page":"152","article-title":"Preclinical Characterization and Clinical Evaluation of Tacrolimus Eye Drops","volume":"120","author":"Luaces-Rodr\u00edguez","year":"2018","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2022.02.010_b0475","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/pharmaceutics12080717","article-title":"Biopharmaceutical Assessment of Dexamethasone Acetate-Based Hydrogels Combining Hydroxypropyl Cyclodextrins and Polysaccharides for Ocular Delivery","volume":"12","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2022.02.010_b0480","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.2042-7158.1986.tb04611.x","article-title":"A Comparison of the Effect of Viscosity on the Precorneal Residence of Solutions in Rabbit and Man","volume":"38","author":"Zaki","year":"1986","journal-title":"J. Pharm. Pharmacol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:48:36Z","timestamp":1760546916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":96,"alternative-id":["S0939641122000315"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.02.010","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}